ROS-related mitochondrial and inflammatory pathways

ROS-related mitochondrial and inflammatory pathways represent a complex network where reactive oxygen species (ROS) produced by mitochondria serve as key mediators of cellular signaling and inflammation (Source: PubMed, PMID: 21248730). Under physiological conditions, mitochondrial ROS are involved in homeostatic signaling; however, excessive production due to mitochondrial dysfunction triggers oxidative stress and activates pro-inflammatory cascades, such as the NLRP3 inflammasome (Source: Nature, doi:10.1038/nature09663). This mitochondrial-inflammatory axis is a central driver in the progression of chronic diseases, including neurodegeneration and cardiovascular disease (Source: NIH, StatPearls). Furthermore, the release of mitochondrial damage-associated molecular patterns (DAMPs), such as mitochondrial DNA, into the cytoplasm further amplifies the immune response by engaging pattern recognition receptors (Source: Science, doi:10.1126/science.1219141). Pharmacological intervention typically involves the use of antioxidants like MitoQ or inhibitors of downstream inflammatory mediators to restore cellular redox balance (Source: Journal of Clinical Investigation, doi:10.1172/JCI127309). Because these pathways are ubiquitous and essential for normal cell function, therapeutic targeting requires high specificity to avoid interfering with vital physiological processes like host defense and mitohormesis.

Other names

Mitochondrial-inflammatory axisMitochondrial ROS signalingmtROS-NLRP3 pathwayReactive oxygen species-mediated mitochondrial signaling

Modulation of mitochondrial redox state and inhibition of ROS-induced inflammatory signaling.